Clinical Trial Update: Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders [Phase 2]

View source ↗

Summary

DoD-sponsored Phase 2 trial evaluating omega-3 EPA/DHA to influence mood and stress-related disorders in soldiers at risk for depression. Conditions include moo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Mood Disorders
• Post-traumatic Stress Disorder
• Stress Disorder

Drugs mentioned

• Omega-3 EPA/DHA (eicosapentaenoic acid / docosahexaenoic acid)

Snippet

Sponsor: United States Department of Defense | Conditions: Mood Disorders, Depression | Phase 2 | Status: UNKNOWN